The authors described a COVID-19 vaccine based on a replication-defective gorilla adenovirus expressing the stabilized pre-fusion SARS-CoV-2 spike protein, named GRAd-COV2.
[Science Immunology]
Sorry, but the selected Zotpress account can't be found.